{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:30:23Z","timestamp":1787020223125,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T00:00:00Z","timestamp":1521504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Lineagen, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12881-018-0555-3","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T22:38:13Z","timestamp":1522795093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Clinical utility of exome sequencing in individuals with large homozygous regions detected by chromosomal microarray analysis"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6786-2313","authenticated-orcid":false,"given":"Aparna","family":"Prasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Sdano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena J.","family":"Vanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Mowery-Rushton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moises A.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles H.","family":"Hensel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Robert","family":"Wassman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,20]]},"reference":[{"key":"555_CR1","first-page":"742","volume":"12","author":"M Manning","year":"2010","unstructured":"Manning M, Hudgins L, Professional Practice and Guidelines Committee. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med Off J Am Coll Med Genet. 2010;12:742\u20135.","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"555_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/ajmg.a.33939","volume":"155A","author":"P Papenhausen","year":"2011","unstructured":"Papenhausen P, Schwartz S, Risheg H, Keitges E, Gadi I, Burnside RD, et al. UPD detection using homozygosity profiling with a SNP genotyping microarray. Am J Med Genet A. 2011;155A:757\u201368.","journal-title":"Am J Med Genet A"},{"key":"555_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.cll.2011.08.003","volume":"31","author":"HM Kearney","year":"2011","unstructured":"Kearney HM, Kearney JB, Conlin LK. Diagnostic implications of excessive homozygosity detected by SNP-based microarrays: consanguinity, uniparental disomy, and recessive single-gene mutations. Clin Lab Med. 2011;31:595\u2013613. ix","journal-title":"Clin Lab Med"},{"key":"555_CR4","doi-asserted-by":"crossref","unstructured":"Hensel C, Vanzo R, Martin M, Dixon S, Lambert C, Levy B, et al. Analytical and clinical validity study of FirstStepDx PLUS: a chromosomal microarray optimized for patients with neurodevelopmental conditions. PLoS Curr. 2017;9","DOI":"10.1371\/currents.eogt.7d92ce775800ef3fbc72e3840fb1bc22"},{"key":"555_CR5","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1093\/bioinformatics\/btq330","volume":"26","author":"W McLaren","year":"2010","unstructured":"McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F. Deriving the consequences of genomic variants with the Ensembl API and SNP effect predictor. Bioinforma Oxf Engl. 2010;26:2069\u201370.","journal-title":"Bioinforma Oxf Engl"},{"key":"555_CR6","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1101\/gr.176601","volume":"11","author":"PC Ng","year":"2001","unstructured":"Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 2001;11:863\u201374.","journal-title":"Genome Res"},{"key":"555_CR7","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1093\/nar\/gkf493","volume":"30","author":"V Ramensky","year":"2002","unstructured":"Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002;30:3894\u2013900.","journal-title":"Nucleic Acids Res"},{"key":"555_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248\u20139.","journal-title":"Nat Methods"},{"key":"555_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285\u201391.","journal-title":"Nature"},{"key":"555_CR10","first-page":"1151","volume":"19","author":"N Whiffin","year":"2017","unstructured":"Whiffin N, Minikel E, Walsh R, O\u2019Donnell-Luria AH, Karczewski K, Ing AY, et al. Using high-resolution variant frequencies to empower clinical genome interpretation. Genet Med Off J Am Coll Med Genet. 2017;19:1151\u20138.","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"555_CR11","first-page":"405","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med Off J Am Coll Med Genet. 2015;17:405\u201324.","journal-title":"Genet Med Off J Am Coll Med Genet."},{"key":"555_CR12","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1126\/science.277.5333.1802","volume":"277","author":"DE Sleat","year":"1997","unstructured":"Sleat DE, Donnelly RJ, Lackland H, Liu CG, Sohar I, Pullarkat RK, et al. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science. 1997;277:1802\u20135.","journal-title":"Science"},{"key":"555_CR13","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/humu.20930","volume":"30","author":"A Tessa","year":"2009","unstructured":"Tessa A, Fiermonte G, Dionisi-Vici C, Paradies E, Baumgartner MR, Chien Y-H, et al. Identification of novel mutations in the SLC25A15 gene in hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome: a clinical, molecular, and functional study. Hum Mutat. 2009;30:741\u20138.","journal-title":"Hum Mutat"},{"key":"555_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13023-015-0242-9","volume":"10","author":"D Martinelli","year":"2015","unstructured":"Martinelli D, Diodato D, Ponzi E, Monn\u00e9 M, Boenzi S, Bertini E, et al. The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome. Orphanet J Rare Dis. 2015;10:29.","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl 3","key":"555_CR15","doi-asserted-by":"publisher","first-page":"S275","DOI":"10.1007\/s10545-010-9148-9","volume":"33","author":"AAH Sokoro","year":"2010","unstructured":"Sokoro AAH, Lepage J, Antonishyn N, McDonald R, Rockman-Greenberg C, Irvine J, et al. Diagnosis and high incidence of hyperornithinemia-hyperammonemia-homocitrullinemia (HHH) syndrome in northern Saskatchewan. J Inherit Metab Dis. 2010;33(Suppl 3):S275\u201381.","journal-title":"J Inherit Metab Dis"},{"key":"555_CR16","volume-title":"GeneReviews(\u00ae) [internet]","author":"J Camacho","year":"1993","unstructured":"Camacho J, Rioseco-Camacho N. Hyperornithinemia-Hyperammonemia-Homocitrullinuria syndrome. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJ, et al., editors. GeneReviews(\u00ae) [internet]. Seattle: University of Washington, Seattle; 1993. [cited 2017 Jan 18]. Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK97260\/\n                    \n                  ."},{"key":"555_CR17","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/humu.10225","volume":"21","author":"P B\u00e9nit","year":"2003","unstructured":"B\u00e9nit P, Beugnot R, Chretien D, Giurgea I, De Lonlay-Debeney P, Issartel J-P, et al. Mutant NDUFV2 subunit of mitochondrial complex I causes early onset hypertrophic cardiomyopathy and encephalopathy. Hum Mutat. 2003;21:582\u20136.","journal-title":"Hum Mutat"},{"key":"555_CR18","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1067\/mpd.2001.118885","volume":"139","author":"M Bar-Meir","year":"2001","unstructured":"Bar-Meir M, Elpeleg ON, Saada A. Effect of various agents on adenosine triphosphate synthesis in mitochondrial complex I deficiency. J Pediatr. 2001;139:868\u201370.","journal-title":"J Pediatr"},{"key":"555_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s13311-013-0176-7","volume":"10","author":"DS Kerr","year":"2013","unstructured":"Kerr DS. Review of clinical trials for mitochondrial disorders: 1997-2012. Neurother J Am Soc Exp Neurother. 2013;10:307\u201319.","journal-title":"Neurother J Am Soc Exp Neurother"},{"key":"555_CR20","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1001\/jama.2014.14601","volume":"312","author":"Y Yang","year":"2014","unstructured":"Yang Y, Muzny DM, Xia F, Niu Z, Person R, Ding Y, et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA. 2014;312:1870\u20139.","journal-title":"JAMA"},{"key":"555_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fncel.2016.00081","volume":"10","author":"C Villa","year":"2016","unstructured":"Villa C, Combi R. Potassium channels and human epileptic phenotypes: an updated overview. Front Cell Neurosci. 2016;10:81.","journal-title":"Front Cell Neurosci"},{"key":"555_CR22","volume-title":"Jaspers basic Mech epilepsies [internet]","author":"R Brenner","year":"2012","unstructured":"Brenner R, Wilcox KS. Potassium Channelopathies of epilepsy. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jaspers basic Mech epilepsies [internet]. 4th ed. Bethesda: National Center for Biotechnology Information (US); 2012. [cited 2016 Dec 15]. Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK98143\/\n                    \n                  .","edition":"4"},{"key":"555_CR23","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1046\/j.1528-1157.2001.08801.x","volume":"42","author":"HA Heilstedt","year":"2001","unstructured":"Heilstedt HA, Burgess DL, Anderson AE, Chedrawi A, Tharp B, Lee O, et al. Loss of the potassium channel beta-subunit gene, KCNAB2, is associated with epilepsy in patients with 1p36 deletion syndrome. Epilepsia. 2001;42:1103\u201311.","journal-title":"Epilepsia"},{"key":"555_CR24","doi-asserted-by":"publisher","first-page":"e0141782","DOI":"10.1371\/journal.pone.0141782","volume":"10","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Kong W, Gao Y, Liu X, Gao K, Xie H, et al. Gene mutation analysis in 253 Chinese children with unexplained epilepsy and intellectual\/developmental disabilities. PLoS One. 2015;10:e0141782.","journal-title":"PLoS One"},{"key":"555_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1523\/JNEUROSCI.2634-10.2011","volume":"31","author":"JJ Perkowski","year":"2011","unstructured":"Perkowski JJ, Murphy GG. Deletion of the mouse homolog of KCNAB2, a gene linked to monosomy 1p36, results in associative memory impairments and amygdala hyperexcitability. J Neurosci. 2011;31:46\u201354.","journal-title":"J Neurosci"},{"key":"555_CR26","first-page":"212","volume":"48","author":"M Grompe","year":"1991","unstructured":"Grompe M, Caskey CT, Fenwick RG. Improved molecular diagnostics for ornithine transcarbamylase deficiency. Am J Hum Genet. 1991;48:212\u201322.","journal-title":"Am J Hum Genet"},{"key":"555_CR27","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/humu.20339","volume":"27","author":"S Yamaguchi","year":"2006","unstructured":"Yamaguchi S, Brailey LL, Morizono H, Bale AE, Tuchman M. Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene. Hum Mutat. 2006;27:626\u201332.","journal-title":"Hum Mutat"},{"key":"555_CR28","first-page":"437","volume":"54","author":"ZW Gong","year":"2016","unstructured":"Gong ZW, Han LS, Ye J, Qiu WJ, Zhang HW, Yu YG, et al. Applying multiplex ligation-dependent probe amplification in the diagnosis of 5 cases with ornithine transcarbamylase deficiency. Zhonghua Er Ke Za Zhi Chin J Pediatr. 2016;54:437\u201340.","journal-title":"Zhonghua Er Ke Za Zhi Chin J Pediatr"},{"key":"555_CR29","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1002\/humu.1380110144","volume":"Suppl 1","author":"A Nishiyori","year":"1998","unstructured":"Nishiyori A, Yoshino M, Tananari Y, Matsuura T, Hoshide R, Mastuda I, et al. Y55D mutation in ornithine transcarbamylase associated with late-onset hyperammonemia in a male. Hum Mutat. 1998;Suppl 1:S131\u20133.","journal-title":"Hum Mutat"},{"key":"555_CR30","doi-asserted-by":"publisher","first-page":"e13996","DOI":"10.1371\/journal.pone.0013996","volume":"5","author":"M Kirin","year":"2010","unstructured":"Kirin M, McQuillan R, Franklin CS, Campbell H, McKeigue PM, Wilson JF. Genomic runs of homozygosity record population history and consanguinity. PLoS One. 2010;5:e13996.","journal-title":"PLoS One"},{"key":"555_CR31","first-page":"209","volume":"19","author":"AM Wenger","year":"2017","unstructured":"Wenger AM, Guturu H, Bernstein JA, Bejerano G. Systematic reanalysis of clinical exome data yields additional diagnoses: implications for providers. Genet Med Off J Am Coll Med Genet. 2017;19:209\u201314.","journal-title":"Genet Med Off J Am Coll Med Genet."},{"key":"555_CR32","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1056\/NEJMoa1306555","volume":"369","author":"Y Yang","year":"2013","unstructured":"Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med. 2013;369:1502\u201311.","journal-title":"N Engl J Med"},{"key":"555_CR33","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1001\/jamapediatrics.2017.1755","volume":"171","author":"TY Tan","year":"2017","unstructured":"Tan TY, Dillon OJ, Stark Z, Schofield D, Alam K, Shrestha R, et al. Diagnostic impact and cost-effectiveness of whole-exome sequencing for ambulant children with suspected monogenic conditions. JAMA Pediatr. 2017;171:855\u201362.","journal-title":"JAMA Pediatr"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-018-0555-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12881-018-0555-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-018-0555-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T20:39:31Z","timestamp":1553027971000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-018-0555-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,20]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["555"],"URL":"https:\/\/doi.org\/10.1186\/s12881-018-0555-3","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,20]]},"assertion":[{"value":"20 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patient DNA samples were collected as part of standard clinical genetic testing by Lineagen, Inc. We obtained a waiver of consent from Western Institutional Review Board (IRB) Protocol No. 20162032, for this retrospective study. All patient data submitted to us for the purposes of clinical testing are covered under this IRB. Data was analyzed in a coded fashion in compliance with our IRB protocol.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"As outlined in the section above, we obtained a waiver of consent from Western Institutional Review Board (IRB) Protocol No. 20162032, for this retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AP, CHH, PAM, MASerrano, RJV and ERW are employees of Lineagen. MASdano has no conflicts to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"46"}}